toxylact: a06ad65 macrogol combinations
The first professional lActological database in the word
Drugs in class A06AD65 (macrogol, combinations) are osmotically acting laxatives based on polyethylene glycol (macrogol) combined with electrolytes, and are considered compatible with breastfeeding because systemic absorption of macrogol is negligible and transfer into milk is not expected.medpedia.framar+7
Pharmacological class and composition
A06AD65
includes macrogol (polyethylene glycol
3350 or 4000) in fixed combination with electrolytes such
as sodium chloride,
potassium chloride, sodium bicarbonate or sodium
sulfate.atcddd.fhi+4
These products are formulated as powders for oral solution
used either for
short‑term treatment of constipation or, more commonly,
for bowel cleansing
before colonoscopy and other endoscopic or radiologic
procedures.drugsporphyria+2
Mechanism of action
Macrogol
is a high‑molecular‑weight polymer
that is not absorbed from the gastrointestinal tract and
remains confined to
the intestinal lumen.ncbi.nlm.nih+2
By binding water and increasing the volume of luminal
fluids, it exerts an
osmotic effect that enhances colonic peristalsis, softens
the stool and
facilitates defecation or rapid bowel cleansing depending
on the dosage
regimen.geneesmiddeleninformatiebank+3
Indications in adults
In
lower doses, macrogol–electrolyte
preparations are indicated for short‑term treatment of
chronic constipation,
including in patients with fecal
impaction.medpedia.framar+2
In higher doses, they are widely used for full bowel
preparation prior to
colonoscopy, barium enema examinations or colorectal
surgery, where complete
evacuation of colonic contents is
required.breastfeeding-and-medication+3
Pharmacokinetics relevant to lactation
Polyethylene
glycol (macrogol) is very poorly
absorbed orally; it is excreted unchanged in the feces,
and systemic exposure
after therapeutic doses is negligible.drugsporphyria+3
Because it does not reach clinically significant plasma
concentrations, passage
into breast milk is not expected, and major reference
sources consider macrogol‑based
laxatives a preferred option in breastfeeding
women.drugs+4
Maternal toxicity and adverse effects
Macrogol
combinations are generally well
tolerated, but gastrointestinal adverse reactions are
frequent, especially
during high‑volume bowel prep: abdominal distension,
cramping, nausea, vomiting
and diarrhea.mims+3
Excessive diarrhea may cause transient loss of water and
electrolytes; rare but
serious events such as electrolyte imbalance, dehydration,
hyponatremia or
intestinal perforation have been reported mainly in
vulnerable patients or when
instructions are not followed.analesdepediatria+3
Lactation safety and infant risk
Multiple
lactation sources emphasize that
macrogol‑based bowel preparations and laxatives can be
used while breastfeeding
without the need to interrupt nursing, because the drug
acts locally in the gut
and does not enter breast milk.breastfeedingnetwork+3
No adverse effects have been reported in breastfed infants
whose mothers
received macrogol combinations at therapeutic doses;
infant exposure is
considered negligible, and routine monitoring beyond usual
clinical observation
is not required.geneesmiddeleninformatiebank+3
Considerations for electrolyte components
The
associated electrolytes (sodium,
potassium, bicarbonate, sulfate, chloride) are present in
quantities designed
to maintain or restore fluid and electrolyte balance
during intensive bowel
cleansing.farmacotherapeutischkompas+3
In healthy breastfeeding women, these ions do not pose
specific risks to the
infant, but maternal conditions such as renal impairment,
cardiac failure or
pre‑existing electrolyte disturbances warrant caution and
possible dose
adjustment.mayoclinic+3
Use during pregnancy and postpartum
SmPC
and clinical guidance documents state that
clinically relevant systemic exposure to macrogol is
negligible, and therefore
no harmful effects during pregnancy and postpartum are
anticipated at
recommended doses.drugs+2
Although animal data show some indirect reproductive
toxicity at very high, maternally
toxic doses, human experience has not identified
teratogenicity or specific
perinatal risks when macrogol combinations are used
appropriately.geneesmiddeleninformatiebank+1
Clinical recommendations in breastfeeding women
For
routine constipation in breastfeeding
mothers, standard doses of macrogol‑electrolyte laxatives
can be used as first‑line
osmotic agents, with attention to adequate oral hydration
and to any underlying
comorbidities.ncbi.nlm.nih+2
For bowel preparation before colonoscopy or similar
procedures, several
breastfeeding‑focused resources explicitly state that
mothers may continue
breastfeeding as usual during and after macrogol‑based
regimens, while being
counselled about transient maternal dehydration, fatigue
or sedation from co‑administered
drugs.s895428841.websitehome+2



